SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-21-003972
Filing Date
2021-05-17
Accepted
2021-05-17 17:11:43
Documents
51
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q inspyrtherapeutics_10q.htm 10-Q 556370
2 EXHIBIT 31.1 inspyrtherapeutics_ex31-1.htm EX-31.1 7518
3 EXHIBIT 31.2 inspyrtherapeutics_ex31-2.htm EX-31.2 7694
4 EXHIBIT 32.1 inspyrtherapeutics_ex32-1.htm EX-32.1 5057
5 EXHIBIT 32.2 inspyrtherapeutics_ex32-2.htm EX-32.2 5132
  Complete submission text file 0001829126-21-003972.txt   2369717

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nspx-20210331.xml EX-101.INS 306049
7 XBRL SCHEMA FILE nspx-20210331.xsd EX-101.SCH 27457
8 XBRL CALCULATION FILE nspx-20210331_cal.xml EX-101.CAL 31290
9 XBRL DEFINITION FILE nspx-20210331_def.xml EX-101.DEF 102527
10 XBRL LABEL FILE nspx-20210331_lab.xml EX-101.LAB 183265
11 XBRL PRESENTATION FILE nspx-20210331_pre.xml EX-101.PRE 152250
Mailing Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361
Business Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 21932229
SIC: 2834 Pharmaceutical Preparations